These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 29461595)
1. MiR-1271 negatively regulates AKT/MTOR signaling and promotes apoptosis via targeting PDK1 in pancreatic cancer. Xie F; Huang Q; Liu CH; Lin XS; Liu Z; Liu LL; Huang DW; Zhou HC Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):678-686. PubMed ID: 29461595 [TBL] [Abstract][Full Text] [Related]
2. Down-regulated microRNA-223 or elevated ZIC1 inhibits the development of pancreatic cancer via inhibiting PI3K/Akt/mTOR signaling pathway activation. Zhu J; Lv J; Chen J; Zhang X; Ji Y Cell Cycle; 2020 Nov; 19(21):2851-2865. PubMed ID: 33064959 [No Abstract] [Full Text] [Related]
3. MiR-1 inhibits prostate cancer PC3 cells proliferation through the Akt/mTOR signaling pathway by binding to c-Met. Gao S; Zhao Z; Wu R; Wu L; Tian X; Zhang Z Biomed Pharmacother; 2019 Jan; 109():1406-1410. PubMed ID: 30551391 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-375 targets PDK1 in pancreatic carcinoma and suppresses cell growth through the Akt signaling pathway. Zhou J; Song S; He S; Zhu X; Zhang Y; Yi B; Zhang B; Qin G; Li D Int J Mol Med; 2014 Apr; 33(4):950-6. PubMed ID: 24481267 [TBL] [Abstract][Full Text] [Related]
5. microRNA-145-3p inhibits non-small cell lung cancer cell migration and invasion by targeting PDK1 via the mTOR signaling pathway. Chen GM; Zheng AJ; Cai J; Han P; Ji HB; Wang LL J Cell Biochem; 2018 Jan; 119(1):885-895. PubMed ID: 28661070 [TBL] [Abstract][Full Text] [Related]
6. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway. Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529 [TBL] [Abstract][Full Text] [Related]
7. Role of miR-489 in the proliferation and apoptosis of pancreatic carcinoma. Zeng M; Zhou Y; Zhang Y; Wang T; Wang J J BUON; 2019; 24(4):1574-1580. PubMed ID: 31646811 [TBL] [Abstract][Full Text] [Related]
8. MiR-128b is down-regulated in gastric cancer and negatively regulates tumour cell viability by targeting PDK1/Akt/NF-κB axis. Zhang L; Lei J; Fang ZL; Xiong JP J Biosci; 2016 Mar; 41(1):77-85. PubMed ID: 26949090 [TBL] [Abstract][Full Text] [Related]
9. LncRNA H19/microRNA-675/PPARα axis regulates liver cell injury and energy metabolism remodelling induced by hepatitis B X protein via Akt/mTOR signalling. Liu Y; Xu L; Lu B; Zhao M; Li L; Sun W; Qiu Z; Zhang B Mol Immunol; 2019 Dec; 116():18-28. PubMed ID: 31574452 [TBL] [Abstract][Full Text] [Related]
10. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway. Dai C; Xie Y; Zhuang X; Yuan Z Biomed Pharmacother; 2018 Aug; 104():763-770. PubMed ID: 29807226 [TBL] [Abstract][Full Text] [Related]
11. MiR-28 inhibits cardiomyocyte survival through suppressing PDK1/Akt/mTOR signaling. Zhu RY; Zhang D; Zou HD; Zuo XS; Zhou QS; Huang H In Vitro Cell Dev Biol Anim; 2016 Dec; 52(10):1020-1025. PubMed ID: 27338735 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway. Li YM; Li XJ; Yang HL; Zhang YB; Li JC Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295 [TBL] [Abstract][Full Text] [Related]
13. The effect of miR-579 on the PI3K/AKT pathway in human glioblastoma PTEN mutant cell lines. Kalhori MR; Irani S; Soleimani M; Arefian E; Kouhkan F J Cell Biochem; 2019 Oct; 120(10):16760-16774. PubMed ID: 31243804 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of miR-138 in patients with malignant melanoma through targeting of PDK1 in the PI3K/AKT autophagy signaling pathway. Meng F; Zhang Y; Li X; Wang J; Wang Z Oncol Rep; 2017 Sep; 38(3):1655-1662. PubMed ID: 28731179 [TBL] [Abstract][Full Text] [Related]
15. MiR-410 exerts neuroprotective effects in a cellular model of Parkinson's disease induced by 6-hydroxydopamine via inhibiting the PTEN/AKT/mTOR signaling pathway. Ge H; Yan Z; Zhu H; Zhao H Exp Mol Pathol; 2019 Aug; 109():16-24. PubMed ID: 31067440 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-195 Suppresses the Progression of Pancreatic Cancer by Targeting DCLK1. Zhou B; Sun C; Hu X; Zhan H; Zou H; Feng Y; Qiu F; Zhang S; Wu L; Zhang B Cell Physiol Biochem; 2017; 44(5):1867-1881. PubMed ID: 29224010 [TBL] [Abstract][Full Text] [Related]
17. miR-138 Reduces the Dysfunction of T Follicular Helper Cells in Osteosarcoma via the PI3K/Akt/mTOR Pathway by Targeting PDK1. Jiang B; Kang X; Zhao G; Lu J; Wang Z Comput Math Methods Med; 2021; 2021():2895893. PubMed ID: 34950224 [TBL] [Abstract][Full Text] [Related]
18. miR-17-5p knockdown inhibits proliferation, autophagy and promotes apoptosis in thyroid cancer via targeting PTEN. Shi YP; Liu GL; Li S; Liu XL Neoplasma; 2020 Mar; 67(2):249-258. PubMed ID: 31973533 [TBL] [Abstract][Full Text] [Related]
19. MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer. Xu S; Ge J; Zhang Z; Zhou W Biomed Pharmacother; 2017 Dec; 96():634-641. PubMed ID: 29035829 [TBL] [Abstract][Full Text] [Related]
20. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling. Tang Y; Xiao G; Chen Y; Deng Y Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]